1.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019-11, Vol.25 (11), p.1753-1760
2.
Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S.
Nature medicine, 2020-08-01, Vol.26 (8), p.1308-1308
3.
Cardiovascular complications of chronic kidney disease
by Lees, Jennifer S
Medicine (Abingdon. 1995, UK ed.), 2015, Vol.43 (8), p.469-473
4.
A Social Commons Ethos in Public Policy-Making
by Lees-Marshment, Jennifer
Journal of business ethics, 2020-07-23, Vol.166 (4), p.761-778
5.
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
by Zhu, Andrew X
The lancet oncology, 2018-07, Vol.19 (7), p.940-952
6.
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission
by WATKINS, Jennifer D
AIDS (London), 2013, Vol.27 (9), p.F13-F20
7.
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model
by von Dadelszen, Peter, Dr
The Lancet (British edition), 2011, Vol.377 (9761), p.219-227
8.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
by Weller, Michael
The lancet oncology, 2017-10, Vol.18 (10), p.1373-1385
9.
Incidence of Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy
by Sugar, Elizabeth A
American journal of ophthalmology, 2012, Vol.153 (6), p.1016-1024.e5
10.
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine
by Green, Robert C
American journal of human genetics, 2016-06-02, Vol.98 (6), p.1051-1066
11.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
by Cardon, Lon R
Nature, 2007, Vol.447 (7145), p.661-678
12.
Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics
by Muus, Christoph
Nature medicine, 2021-03, Vol.27 (3), p.546-559
13.
Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases
by Trynka, Gosia
American journal of human genetics, 2014-11-06, Vol.95 (5), p.535-552
14.
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease
by Gladstone, R.A
Vaccine, 2022-02-11, Vol.40 (7), p.1054-1060
15.
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
by Nejentsev, Sergey
Nature, 2007-12-06, Vol.450 (7171), p.887-892
16.
Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline
by Hill, Jennifer
Heart, 2010-06, Vol.96 (11), p.879-882
17.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, do...
by Petrylak, Daniel P
The Lancet (British edition), 2017-11-18, Vol.390 (10109), p.2266-2277
18.
Simons Variation in Individuals Project (Simons VIP): A Genetics-First Approach to Studying Autism Spectrum and Related Neurodevelopmental Disorders
by Consortium, The Simons Vip
Neuron (Cambridge, Mass.), 2012-03-22, Vol.73 (6), p.1063-1067
19.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
by Ripke, Stephan
American journal of human genetics, 2015-10-01, Vol.97 (4), p.576-592
20.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
by Gaudinski, Martin R Martin R
The Lancet (British edition), 2017-12-05, Vol.391 (10120), p.552-562
